BETA
Start SIP
Invest Now
Start SIP in BETA
Performance
- Low
- ₹1,578
- High
- ₹1,615
- 52 Week Low
- ₹1,430
- 52 Week High
- ₹2,046
- Open Price₹1,615
- Previous Close₹1,578
- Volume3,029
Investment Returns
- Over 1 Month -1.65%
- Over 3 Month -13.32%
- Over 6 Month -10.91%
- Over 1 Year -14.32%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,605
- P/B Ratio
- 7.3
- Average True Range
- 69.68
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- -31.42
- RSI
- 43.39
- MFI
- 18.89
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,590.30
+
12
(0.76%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹1,619.68
- 50 Day
- ₹1,675.80
- 100 Day
- ₹1,721.91
- 200 Day
- ₹1,734.16
Resistance and Support
1594.4
- R3 1,648.00
- R2 1,631.50
- R1 1,610.90
- S1 1,573.80
- S2 1,557.30
- S3 1,536.70
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2024-11-06 | Quarterly Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,590 As on 26 December, 2025 | 01:17
The Market Cap of Beta Drugs is ₹1605.3 Cr As on 26 December, 2025 | 01:17
The P/E ratio of Beta Drugs is As on 26 December, 2025 | 01:17
The PB ratio of Beta Drugs is 7.3 As on 26 December, 2025 | 01:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.